Hematopoietic growth factors in neonatal medicine: The use of enterally administered hematopoietic growth factors in the neonatal intensive care unit

Clinics in Perinatology

Volumn 31, Issue 1, 2004, Pages 169-182

  Calhoun, Darlene A ^a   Christensen, Robert D ^a  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOPOIETIC GROWTH FACTOR; NOVEL ERYTHROPOIESIS STIMULATING PROTEIN; RECOMBINANT ERYTHROPOIETIN; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

AMNION FLUID; AUTOLYSIS; CELL ULTRASTRUCTURE; COLOSTRUM; DRUG ABSORPTION; DRUG EFFECT; DRUG SAFETY; ENTERIC FEEDING; FETUS DEVELOPMENT; GESTATIONAL AGE; HISTOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; INFANT FEEDING; INTESTINE OBSTRUCTION; INTESTINE VILLUS; MEDICAL ASSESSMENT; NEWBORN; NEWBORN INTENSIVE CARE; NONHUMAN; NUTRITIONAL SUPPORT; PREMATURITY; PRIORITY JOURNAL; REVIEW;

AMNIOTIC FLUID; ANIMALS; EMBRYONIC AND FETAL DEVELOPMENT; HEMATOPOIETIC CELL GROWTH FACTORS; HUMANS; INFANT NUTRITION PHYSIOLOGY; INFANT, NEWBORN; INTENSIVE CARE UNITS, NEONATAL; INTESTINES; INTUBATION, GASTROINTESTINAL; NEONATOLOGY; SOLUTIONS;

EID: 2942536238     PISSN: 00955108     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clp.2004.03.001     Document Type: Review

References (33)

1. Calhoun D., Juul S., McBryde E., Veerman M., Christensen R. Stability of Filgrastim and Epoetin Alfa in a system designed for enteral administration in neonates. Ann Pharmacother. 34:2000;1257-1261
2. Calhoun D.A., Chegini N., Polliotti B.M., Gersting J.A., Miller R.K., Christensen R.D. Granulocyte colony-stimulating factor in preterm and term pregnancy, parturition, and intra-amniotic infection. Obstet Gynecol. 97:2001;229-234
3. Clapp J., Little K., Appleby-Wineberg S., Widness J. The effect of regular maternal excercise on erythropoietin in cord blood and amniotic fluid. Am J Obstet Gynecol. 172:1995;1445-1451
4. Calhoun D.A., Richards B.E., Gersting J.A., Sullivan S.E., Christensen R.D. G-CSF and Epo stability in amniotic fluid during simulated in vitro digestion conditions. J Pharm Technol. 18:2002;310-315
5. Ross M., Nijland M. Fetal swallowing:relation to amniotic fluid regulation. Clin Obstet Gynecol. 40:1997;352-365
6. Berseth C. Enhancement of intestinal growth in neonatal rats by epidermal growth factor in milk. Am J Physiol. 253:1987;G662-G665
7. Trahair J., Harding R. Restitution of swallowing in the fetal sheep restores intestinal growth after midgestation esophageal obstruction. J Pediatr Gastroenterol Nutr. 20:1995;156-161
8. Karnak I., Tanyel F., Muftuoglu S., Unsal I., Cakar N., Buyukpamukcu N., et al. Esophageal ligation: effects on the development of fetal organic systems. Eur J Pediatr Surg. 6:1996;328-333
9. Hernandez G., Velasco N., Wainstein C., Castillo L., Bugedo G., Maiz A., et al. Gut mucosal atrophy after a short enteral fasting period in critically ill patients. J Crit Care. 14:1999;73-77
10. Jolleys A. An examnination of the birthweights of babies with some abnormalities of the alimentary tract. J Pediatr Surg. 16:1981;160-163
11. Pierro A., Cozzi F., Colarossi G., Irving I.M., Pierce A.M., Lister J. Does fetal gut obstruction cause hydramnios and growth retardation? J Pediatr Surg. 22:1987;454-457
12. Cozzi F., Wilkinson A. Low birthweight babies with oesophageal atresia or tracheo-oesophageal fistula. Arch Dis Child. 50:1975;791-795
13. Condino A., Barleycorn A., Lu W., Maheshwari A., Christensen R.D., Calhoun D.A. Abnormal intestinal histology in neonates with congenital anomalies of the gastrointestinal tract. Biol Neonate. 85:2004;145-150
14. Burrin D.G., Stoll B. Key nutrients and growth factors for the neonatal gastrointestinal tract. Clin Perinatol. 29:2002;65-96
15. Maheshwari A., Mathai J., Christensen R.D., Calhoun D.A. The practice of bowel rest in neonates receiving intensive care directly impacts the total duration of hospital stay [abstract]. Pediatr Res, in press
16. Kuzma-O'Reilly B., Duenas M.L., Greecher C., Kimberlin L., Mujsce D., Miller D., et al. Evaluation, development, and implementation of potentially better practices in neonatal intensive care nutrition. Pediatrics. 111:2003;e461-e470
17. Calhoun D., Lunoe M., Du Y., Christensen R. Granulocyte colony-stimulating factor (G-CSF) is present in human milk and its receptor (G-CSF-R) is present in human fetal intestine [online serial]. Pediatrics. 105:2000;e7
18. Calhoun D.A., Donnelly W.H. Jr., Du Y., Dame J.B., Li Y., Christensen R.D. Distribution of granulocyte colony-stimulating factor (G-CSF) and G-CSF-receptor mRNA and protein in the human fetus. Pediatr Res. 46:1999;333-338
19. Gersting J.A., Kotto-Kome A.C., Du Y., Christensen R.D., Calhoun D.A. Bioavailability of granulocyte colony-stimulating factor administered enterally to suckling mice. Pharmacol Res. 48:2003;643-647
20. Gersting J.A., Christensen R.D., Calhoun D.A. The effects of enterally administering granulocyte colony stimulating factor to suckling mice. Pediatr Res. 55(5):2004;802-806
21. Calhoun D.A., Maheshwari A., Christensen R.D. Recombinant granulocyte colony-stimulating factor administered enterally to neonates is not absorbed. Pediatrics. 112:2003;421-423
22. Kling P., Sullivan T., Roberts R., Phillips A., Koldovsky O. Human milk as a potential enteral source of erythropoietin. Pediatr Res. 43:1998;216-221
23. Koldovsky O. The potential physiological significance of milk-borne hormonally active substances for the neonate. J Mamm Gland Biol Neoplasia. 1:1996;317-322
24. Juul S., Joyce A., Zhao Y., Ledbetter D. Why is erythropoietin present in human milk? Studies of erythropoietin receptors on enterocytes of human and rat neonates. Pediatr Res. 46:1999;263-268
25. Juul S.E. Erythropoietin in the neonate. Curr Probl Pediatr. 29:1999;129-149
26. Britton J., Christensen R. Enteral administration of recombinant erythropoietin to preterm infants. J Perinatol. 15:1995;281-283
27. Ballin A., Bilker-Reich A., Arbel E., Davidovitz Y., Kohelet D. Erythropoietin, given enterally, stimulates erythropoiesis in premature infants. Lancet. 353:1999;1849
28. Sullivan S.E., Calhoun D.A., Maheshwari A., Ashmeade T.L., Auerbach D.A., Hudak M.L., et al. Tolerance of simulated amniotic fluid in premature neonates. Ann Pharmacother. 36:2002;1518-1524
29. Lima-Rogel V., Calhoun D.A., Maheshwari A., Torres-Montes A., Roque-Sanchez R., Garcia M.G., et al. Tolerance of a sterile isotonic electrolyte solution containing select recombinant growth factors in neonates recovering from necrotizing enterocolitis. J Perinatol. 23:2003;200-204
30. Lima-Rogel V., Ojeda M., Villegas C., Torres-Montes A., Medrano S., Calhoun D.A., et al. Tolerance of enterally-administered simulated amniotic fluid-like solution by neonates recovering from surgery for congenital bowel abnormalities. J Perinatol. 2004;. In press
31. Cases A. Darbepoetin alfa: a novel erythropoiesis-stimulating protein. Drug Today (Barc). 39:2003;477-495
32. Zamboni W.C. Pharmacokinetics of pegfilgrastim. Pharmacotherapy. 23:2003;9S-14S
33. Jensen-Pippo K.E., Whitcomb K.L., DePrince R.B., Ralph L., Habberfield A.D. Enteral bioavailability of human granulocyte colony stimulating factor conjugated with poly(ethylene glycol). Pharm Res. 13:1996;102-107